Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2024 09:10 ET | Source: Polaris Market Research & Consulting LLP

Global Laboratory Developed Tests Market Worth USD 22.30 Billion, Growing at a 6.9% CAGR from 2024 to 2032 - Report by Polaris Market Research (PMR)

New York, May 22, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Global Laboratory Developed Tests Market was valued at USD 12.21 billion in 2023 and is anticipated to generate an estimated revenue...
June 29, 2017 05:00 ET | Source: BCC Research

Global Market for LDT Evolving, Shifting, and Growing (6.3% CAGR)

Wellesley, Mass., June 29, 2017 (GLOBE NEWSWIRE) -- The laboratory-developed test (LDT) market is evolving due to a variety of technological, financial and regulatory factors that will shift the...
July 16, 2014 14:45 ET | Source: ARUP Laboratories

Laboratory Heads from World-Renowned Academic Medical Centers Urge OMB Not to Release FDA Guidance on the Regulation of Laboratory-Developed Tests (LDTs)

SALT LAKE CITY, July 16, 2014 (GLOBE NEWSWIRE) -- Leading diagnostic innovators and laboratory directors from the nation's most respected nonprofit, academic medical centers have issued a letter...
September 23, 2013 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Conduct Free Webinar: How to Invest Ahead of Breast Cancer Awareness Month

SEATTLE, WA--(Marketwired - Sep 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, today announced that Dr. Steven C. Quay, Chairman, President & CEO, will...
June 05, 2013 08:30 ET | Source: Atossa Genetics, Inc.

Peter J. Carbonaro Joins Atossa Genetics as Senior Vice President of Operations

SEATTLE, WA--(Marketwired - Jun 5, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Peter J. Carbonaro has joined the Company as Senior Vice...
May 14, 2013 08:30 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Present at the Sachs Associates Cancer Bio Partnering Forum and Participate on the Cancer Tech Panel

SEATTLE, WA--(Marketwired - May 14, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Dr. Steven Quay, Chairman, CEO & President, will speak...